Ligand Binding Kinetics and Equilibrium

Binding is not instantaneous: a ligand associates with and dissociates from its receptor at finite rates, and the balance between the two sets both the equilibrium affinity and the time course of the interaction. Kinetics asks not only how much ligand is bound at steady state but how quickly that state is reached and how long the complex lasts.

Definition

Ligand binding kinetics describes the time-dependent association and dissociation of a ligand with its binding site, governed by the association rate constant (kon) and dissociation rate constant (koff), whose ratio defines the equilibrium dissociation constant (Kd = koff/kon) that characterises the binding at steady state.

Scope

This topic covers the rate constants of ligand association and dissociation, their relationship to the equilibrium dissociation constant, the concept of residence time, and the way binding is measured and analysed in radioligand and related assays, including the conversion between observed inhibition and the underlying affinity constant. It is reference material in pharmacodynamics and offers no dosing guidance.

Core questions

• How fast does a ligand bind to and unbind from its receptor?
• How do the association and dissociation rate constants determine equilibrium affinity?
• What is residence time, and why might the duration of binding matter?
• How are binding parameters extracted from radioligand saturation and competition experiments?

Key concepts

• Association rate constant (kon)
• Dissociation rate constant (koff)
• Equilibrium dissociation constant (Kd = koff/kon)
• Residence time
• Saturation binding and Scatchard analysis
• Competition binding (IC50, Ki)
• Specific versus non-specific binding

Key theories

Mass-action binding kinetics

The framework treating ligand-receptor association as a bimolecular reaction governed by kon and koff, predicting the time course of binding and the equilibrium occupancy through the law of mass action.

Cheng-Prusoff relationship

The relation that converts the concentration of a competitor producing half-maximal inhibition (IC50) in a binding assay into the competitor's true affinity constant (Ki), correcting for the radioligand concentration and its affinity.

Mechanisms

Ligand and receptor combine at a rate set by the association rate constant kon and the concentrations of free ligand and free receptor, while the complex breaks down at a rate set by the dissociation rate constant koff; at equilibrium the two opposing processes balance, and their ratio defines the equilibrium dissociation constant, Kd = koff/kon. The same equilibrium affinity can arise from very different rate pairs, so two ligands with identical Kd may differ greatly in how fast they bind and, in particular, in how slowly they leave—captured by the residence time, the average lifetime of the complex. In the laboratory these quantities are recovered from kinetic time-course experiments and from equilibrium saturation assays, while competition assays measure the concentration of an unlabelled ligand that displaces half of a radioligand; the Cheng-Prusoff relationship then converts that half-inhibition concentration into the ligand's affinity constant by correcting for the radioligand used. Motulsky and Mahan derived the kinetics expected when a labelled and an unlabelled ligand compete, allowing rate constants to be estimated from such experiments.

Clinical relevance

Binding kinetics inform how the rate and persistence of target engagement are characterised, and the residence-time concept is one way of reasoning about why some interactions outlast the presence of free drug. These are reference principles for interpreting binding data and do not provide instructions for dosing or treatment.

Evidence & guidelines

Kinetic and equilibrium binding analysis is grounded in laboratory pharmacology and standardised methodology rather than clinical guidelines; the quantitative conventions are set out in standard references and the International Union of Basic and Clinical Pharmacology (IUPHAR) nomenclature.

History

Quantitative binding analysis matured with the introduction of radioligand methods in the 1970s, which let receptor numbers and affinities be measured directly. Cheng and Prusoff's 1973 relationship made competition assays interpretable in terms of true affinity, and Motulsky and Mahan's 1984 treatment provided the kinetic theory for competitive binding experiments. Colquhoun's mechanistic work connected these measured constants to the underlying single-receptor binding and gating processes.

Key figures

• David Colquhoun
• Harvey J. Motulsky
• Yung-Chi Cheng
• William H. Prusoff

Seminal works

• cheng-prusoff-1973
• motulsky-mahan-1984

Frequently asked questions

Can two drugs have the same affinity but different kinetics?

Yes. Affinity is the ratio of the dissociation to the association rate constant, so two drugs can share the same equilibrium affinity while binding and unbinding at very different speeds, which gives them different residence times.

What does the Cheng-Prusoff equation do?

It converts the concentration of a competitor that half-inhibits radioligand binding (IC50) into the competitor's true affinity constant (Ki), correcting for the concentration and affinity of the radioligand used in the assay.